Jiban Jyoti Panda

2.6k total citations · 1 hit paper
70 papers, 1.9k citations indexed

About

Jiban Jyoti Panda is a scholar working on Biomaterials, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Jiban Jyoti Panda has authored 70 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Biomaterials, 30 papers in Molecular Biology and 24 papers in Biomedical Engineering. Recurrent topics in Jiban Jyoti Panda's work include Supramolecular Self-Assembly in Materials (22 papers), RNA Interference and Gene Delivery (14 papers) and Advanced biosensing and bioanalysis techniques (14 papers). Jiban Jyoti Panda is often cited by papers focused on Supramolecular Self-Assembly in Materials (22 papers), RNA Interference and Gene Delivery (14 papers) and Advanced biosensing and bioanalysis techniques (14 papers). Jiban Jyoti Panda collaborates with scholars based in India, Italy and United States. Jiban Jyoti Panda's co-authors include Virander S. Chauhan, Sanjeeb Kumar Sahoo, Suphiya Parveen, Aseem Mishra, Atanu Basu, Avneet Kour, Manju Sharma, Shadab Alam, Kusum Harjai and Sanjay Chhibber and has published in prestigious journals such as Hepatology, Langmuir and Scientific Reports.

In The Last Decade

Jiban Jyoti Panda

66 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The present and future of nanotechnology in human health care

2007 601 citations Sanjeeb Kumar Sahoo, Suphiya Parveen et al. Nanomedicine Nanotechnology Biology and Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiban Jyoti Panda India	20	847	740	489	486	304	70	1.9k
Marya Ahmed Canada	30	595 0.7×	1.1k 1.5×	462 0.9×	376 0.8×	455 1.5×	71	2.2k
Mehdi Shafiee Ardestani Iran	27	511 0.6×	620 0.8×	582 1.2×	545 1.1×	202 0.7×	129	2.3k
Karolina H. Markiewicz Poland	16	661 0.8×	433 0.6×	543 1.1×	437 0.9×	203 0.7×	55	2.1k
Jiaqing Wang China	26	620 0.7×	706 1.0×	434 0.9×	213 0.4×	231 0.8×	82	1.7k
Pradeep Kumar India	31	730 0.9×	1.6k 2.1×	669 1.4×	469 1.0×	394 1.3×	163	3.1k
Mahmoud Y. Alkawareek Jordan	15	860 1.0×	966 1.3×	860 1.8×	685 1.4×	154 0.5×	27	3.0k
Aasheesh Srivastava India	29	836 1.0×	547 0.7×	397 0.8×	661 1.4×	655 2.2×	82	2.3k
Pan He China	25	495 0.6×	634 0.9×	524 1.1×	323 0.7×	367 1.2×	88	1.9k
Mingtao Liang Australia	22	975 1.2×	792 1.1×	618 1.3×	607 1.2×	193 0.6×	58	2.2k
Chang Li China	28	506 0.6×	591 0.8×	457 0.9×	502 1.0×	282 0.9×	94	2.1k

Countries citing papers authored by Jiban Jyoti Panda

Since Specialization

Citations

This map shows the geographic impact of Jiban Jyoti Panda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiban Jyoti Panda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiban Jyoti Panda more than expected).

Fields of papers citing papers by Jiban Jyoti Panda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiban Jyoti Panda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiban Jyoti Panda. The network helps show where Jiban Jyoti Panda may publish in the future.

Co-authorship network of co-authors of Jiban Jyoti Panda

This figure shows the co-authorship network connecting the top 25 collaborators of Jiban Jyoti Panda. A scholar is included among the top collaborators of Jiban Jyoti Panda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiban Jyoti Panda. Jiban Jyoti Panda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mishra, Richa, et al.. (2025). LPS-focused nanomedicine for potent antibacterial therapy. Nanomedicine. 20(24). 2971–2992.

Panda, Himanshu Sekhar, et al.. (2025). Revolutionizing Precision Medicine: Unveiling Smart Stimuli‐Responsive Nanomedicine. Advanced Therapeutics. 8(8). 5 indexed citations

Panda, Jiban Jyoti, et al.. (2024). Exploiting flow manipulation to engineer the electroactive phase for improved piezo response in size tunable PVDF microspheres via microfluidic technology. Chemical Engineering Journal. 491. 151986–151986. 9 indexed citations

Panda, Himanshu Sekhar, et al.. (2024). Emerging biosensors in Phenylketonuria. Clinica Chimica Acta. 559. 119725–119725. 4 indexed citations

Kumar, Sushil, et al.. (2024). Short term biodistribution and in vivo toxicity assessment of intravenously injected pristine graphene oxide nanoflakes in SD rats. Toxicology Research. 13(2). tfae058–tfae058. 3 indexed citations

Sharma, Manju, Anand Babu, Varun Gupta, et al.. (2024). Futuristic Alzheimer's therapy: acoustic-stimulated piezoelectric nanospheres for amyloid reduction. Biomaterials Science. 12(7). 1801–1821. 3 indexed citations

Panda, Jiban Jyoti, et al.. (2023). Anti-Glioma Activity Achieved by Dual Blood–Brain Barrier/Glioma Targeting Naive Chimeric Peptides-Based Co-Assembled Nanophototheranostics. Pharmaceutics. 15(1). 265–265. 4 indexed citations

Kour, Avneet, Virendra Tiwari, Himanshu Sekhar Panda, et al.. (2023). Anti-amyloidogenic amphipathic arginine-dehydrophenylalanine spheres capped selenium nanoparticles as potent therapeutic moieties for Alzheimer's disease. Nanoscale. 15(30). 12748–12770. 4 indexed citations

Aggarwal, Nidhi, et al.. (2023). Small Peptide–Based Nanodelivery Systems for Cancer Therapy and Diagnosis. Journal of Pharmacology and Experimental Therapeutics. 390(1). 30–44. 5 indexed citations

10.

Kompella, Uday B., et al.. (2022). Near infrared triggered chemo-PTT-PDT effect mediated by glioma directed twin functional-chimeric peptide-decorated gold nanoroses. Journal of Photochemistry and Photobiology B Biology. 228. 112407–112407. 20 indexed citations

11.

Sharma, Manju, et al.. (2022). Self-Fluorescent Lone Tryptophan Nanoparticles as Theranostic Agents Against Alzheimer’s Disease. ACS Applied Materials & Interfaces. 14(11). 13079–13093. 10 indexed citations

12.

Panda, Jiban Jyoti, et al.. (2021). Aptamer-nanoconjugates as emerging theranostic systems in neurodegenerative disorders. Colloids and Interface Science Communications. 46. 100554–100554. 6 indexed citations

13.

Singh, Manish, et al.. (2021). Miniatured Fluidics-Mediated Modular Self-Assembly of Anticancer Drug–Amino Acid Composite Microbowls for Combined Chemo-Photodynamic Therapy in Glioma. ACS Biomaterials Science & Engineering. 7(12). 5654–5665. 9 indexed citations

14.

Bourne, David W. A., Jiban Jyoti Panda, Stephanie Choi, et al.. (2020). Effect of Particle Size and Viscosity of Suspensions on Topical Ocular Bioavailability of Budesonide, a Corticosteroid. Journal of Ocular Pharmacology and Therapeutics. 36(6). 404–409. 8 indexed citations

15.

Kour, Avneet, Amit Singh Yadav, Manish Singh, et al.. (2020). Continuous flow fabrication of Fmoc-cysteine based nanobowl infused core–shell like microstructures for pH switchable on-demand anti-cancer drug delivery. Biomaterials Science. 9(3). 942–959. 8 indexed citations

16.

Kaur, Jasjeet, Avneet Kour, Jiban Jyoti Panda, Kusum Harjai, & Sanjay Chhibber. (2020). Exploring Endolysin-Loaded Alginate-Chitosan Nanoparticles as Future Remedy for Staphylococcal Infections. AAPS PharmSciTech. 21(6). 233–233. 45 indexed citations

17.

Kompella, Uday B., et al.. (2020). Repurposed Drugs, Molecular Vaccines, Immune‐Modulators, and Nanotherapeutics to Treat and Prevent COVID‐19 Associated with SARS‐CoV‐2, a Deadly Nanovector. Advanced Therapeutics. 4(2). 2000172–2000172. 25 indexed citations

18.

Panda, Jiban Jyoti, Avishek Singh, Nitin Yadav, et al.. (2017). Targeted delivery of microRNA‐199a‐3p using self‐assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma in mice. Hepatology. 67(4). 1392–1407. 63 indexed citations

19.

Panda, Jiban Jyoti, et al.. (2017). Nanoparticles generated from a tryptophan derivative: physical characterization and anti-cancer drug delivery. Amino Acids. 49(5). 975–993. 19 indexed citations

20.

Sahoo, Sanjeeb Kumar, Suphiya Parveen, & Jiban Jyoti Panda. (2007). The present and future of nanotechnology in human health care. Nanomedicine Nanotechnology Biology and Medicine. 3(1). 20–31. 601 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact